🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalCanadian GLP-1 coverage — anyone have experience? Page 6

Canadian GLP-1 coverage — anyone have experience?

lisa_labSD Thu, Apr 2, 2026 at 1:16 AM 36 replies 1,378 viewsPage 6 of 8
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Apr 9, 2026 at 3:21 PM#26

Adding the numbers, since they settle part of this. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Correct me if the detail matters more than I have assumed.

19 17JenMemphis, pat_auckland, Dr.GastroMayo and 16 others
Reply Quote Save Share Report
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Apr 10, 2026 at 11:38 AM#27

One thing that is still open after EndoResFellow’s answer:

Was that from a primary source or from a summary of one?

20 18mike_mod, SarahChen_PharmD, sarah.morrison and 17 others
Reply Quote Save Share Report
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Apr 11, 2026 at 7:54 AM#28
LabKate said:
If you are going to change something, change one thing and give it long enough to express itself.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

21 19amsterdam_pete, LondonLisa, mike_nyc and 18 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Apr 12, 2026 at 4:10 AM#29
LabKate said:
If you are going to change something, change one thing and give it long enough to express itself.

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

Last edited: Apr 12, 2026 at 6:10 AM
22 20KarenAZ_mom, zoe_NC, Dr.ObesityLA and 19 others
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Apr 13, 2026 at 12:25 AM#30

Reporting back.

Follow-up — getting the denial reason in writing was the step that mattered. It named the criterion, and the criterion was a document I already had.

44 17cory_ATX, lori_vegas, Dr.PulmRoch and 41 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register